52 Among patients undergoing bio-enteric IGB placement, the prevalence of hypertension, diabetes, hypercholesterolemia, and osteoarthropathy decreased from 29%, 15%, 32%, and 25% (pre-IGB), respectively, to 16%, 10%, 21%, and 13% at 3 years post-IGB removal
The FDA has previously warned that some of its marketing claims are misleading, so it is not equivalent to approved drugs like Wegovy or Ozempic
The result is reduced cravings, smaller portion sizes, and greater satisfaction after mealsremoving two of the biggest hurdles in any weight loss journey
Aim for 2535 grams of protein per meal to preserve muscle mass and extend satietythis includes eggs, Greek yogurt, fish, chicken, legumes, and tofu
Whether youre just beginning your GLP-1 journey or looking to restore facial volume after major weight loss, well create a custom treatment plan tailored to your goals